======= DSE ======= == Gene Information == * **Official Symbol**: DSE * **Official Name**: dermatan sulfate epimerase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29940|29940]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UL01|Q9UL01]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DSE&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DSE|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605942|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a tumor-rejection antigen. It is localized to the endoplasmic reticulum and functions to convert D-glucuronic acid to L-iduronic acid during the biosynthesis of dermatan sulfate. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. Mutations in this gene cause inmusculocontractural Ehlers-Danlos syndrome. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 9, and a paralogous gene exists on chromosome 18. [provided by RefSeq, Apr 2016]. * **UniProt Summary**: Converts D-glucuronic acid to L-iduronic acid (IdoUA) residues. {ECO:0000269|PubMed:16505484}. No Pfam Domain information is available for this gene. |chondroitin-glucuronate 5-epimerase activity| |dermatan sulfate biosynthetic process| |dermatan sulfate metabolic process| |dermatan sulfate proteoglycan biosynthetic process| |dermatan sulfate proteoglycan metabolic process| |chondroitin sulfate biosynthetic process| |heparan sulfate proteoglycan biosynthetic process| |chondroitin sulfate proteoglycan biosynthetic process| |heparan sulfate proteoglycan metabolic process| |chondroitin sulfate metabolic process| |chondroitin sulfate proteoglycan metabolic process| |proteoglycan biosynthetic process| |proteoglycan metabolic process| |glycosaminoglycan biosynthetic process| |mucopolysaccharide metabolic process| |aminoglycan biosynthetic process| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |sulfur compound biosynthetic process| |monocarboxylic acid biosynthetic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |glycoprotein biosynthetic process| |sulfur compound metabolic process| |glycoprotein metabolic process| |drug metabolic process| |monocarboxylic acid metabolic process| |small molecule biosynthetic process| |Golgi membrane| |carbohydrate derivative biosynthetic process| |carboxylic acid metabolic process| |Golgi apparatus| |oxoacid metabolic process| |endoplasmic reticulum| |organic acid metabolic process| |carbohydrate derivative metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp239|PFI-2 4μM R05 exp239]]|-1.8| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|-1.73| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12423 * **Expression level (log2 read counts)**: 5.18 {{:chemogenomics:nalm6 dist.png?nolink |}}